Small Molecules Attract Investors As Two Chinese Biotechs Bag $161m
19 May 2022 //
SCRIP
Reistone’s topical treatment meets primary goal in dermatitis trial
12 Oct 2021 //
CLINICALTRIALSARENA
Reistone Announces Positive Results from a Phase II Study Evaluating SHR0302
11 Oct 2021 //
PRNEWSWIRE
Reistone Announces Positive Topline Phase 2 Results for SHR0302
24 Aug 2021 //
PRNEWSWIRE
Immunocore`s bispecific gets speedy review with FDA, EMA; Xalud grabs $30M
24 Aug 2021 //
ENDPTS
Reistone Announces First Patient Dosed in Phase III Global Study in Atopic
13 May 2021 //
PRNEWSWIRE
Positive Ph 2 Results for Reistone`s JAK Inhibitor Demonstrate Significant
04 Feb 2021 //
PRNNEWSWIRE